Literature DB >> 17134909

Outcome of lung transplanted patients with primary graft dysfunction.

Christopher M Burton1, Martin Iversen, Nils Milman, Mikhail Zemtsovski, Jørn Carlsen, Daniel Steinbrüchel, Jann Mortensen, Claus B Andersen.   

Abstract

OBJECTIVE: Primary graft dysfunction (PGD) causes significant mortality and morbidity after lung transplantation. The objectives of the study were to describe the clinical and histological sequelae of PGD.
METHODS: Histology of all patients receiving single-lung transplantation 1999-2004 (n=181) was reviewed. PGD was defined as diffuse radiological infiltration of the lung allograft occurring within the first 72h postoperatively.
RESULTS: One patient died intra-operatively. PGD was recorded in 63% (n=113) of 180 consecutive transplant recipients. Patients with PGD had a worse 90-day postoperative mortality (14% versus 3%, p=0.03) and 3-year survival (55% versus 77%, p=0.003). Freedom from bronchiolitis obliterans syndrome was similar in both groups. The maximal FEV(1) was significantly lower in patients with PGD, median 54% (quartiles 48-61%) predicted; compared to patients without PGD, median 59% (quartiles 54-69%) predicted (p=0.003). There was a significant linear trend in the decline of maximal FEV(1) with the presence and increasing severity of radiographic infiltrate (p=0.004). During follow-up, patients with PGD were more likely to demonstrate diffuse alveolar damage or bronchiolitis obliterans organizing pneumonia (p=0.009 and p=0.01, respectively). Histological findings of diffuse alveolar damage correlated closely with extent of radiological infiltration (p<0.0001).
CONCLUSIONS: Transplant recipient survival, lung function, and histological findings of diffuse alveolar damage appear to be closely correlated with the appearance and severity of PGD.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17134909     DOI: 10.1016/j.ejcts.2006.10.024

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  14 in total

1.  Scintigraphy at 3 months after single lung transplantation and observations of primary graft dysfunction and lung function.

Authors:  Esther Okeke Belmaati; Martin Iversen; Klaus F Kofoed; Michael B Nielsen; Jann Mortensen
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-03-09

2.  Integrative analysis correlates donor transcripts to recipient autoantibodies in primary graft dysfunction after lung transplantation.

Authors:  Peter H Hagedorn; Christopher M Burton; Eli Sahar; Eytan Domany; Irun R Cohen; Henrik Flyvbjerg; Martin Iversen
Journal:  Immunology       Date:  2010-11-11       Impact factor: 7.397

3.  The Role of TGF-β in the Association Between Primary Graft Dysfunction and Bronchiolitis Obliterans Syndrome.

Authors:  A DerHovanessian; S S Weigt; V Palchevskiy; M Y Shino; D M Sayah; A L Gregson; P W Noble; S M Palmer; M C Fishbein; B M Kubak; A Ardehali; D J Ross; R Saggar; J P Lynch; R M Elashoff; J A Belperio
Journal:  Am J Transplant       Date:  2015-10-13       Impact factor: 8.086

4.  A panel of lung injury biomarkers enhances the definition of primary graft dysfunction (PGD) after lung transplantation.

Authors:  Rupal J Shah; Scarlett L Bellamy; A Russell Localio; Nancy Wickersham; Joshua M Diamond; Ann Weinacker; Vibha N Lama; Sangeeta Bhorade; John A Belperio; Maria Crespo; Ejigayehu Demissie; Steven M Kawut; Keith M Wille; David J Lederer; James C Lee; Scott M Palmer; Jonathan Orens; John Reynolds; Ashish Shah; David S Wilkes; Lorraine B Ware; Jason D Christie
Journal:  J Heart Lung Transplant       Date:  2012-06-12       Impact factor: 10.247

5.  Aspergillus infection in lung transplant patients: incidence and prognosis.

Authors:  M Iversen; C M Burton; S Vand; L Skovfoged; J Carlsen; N Milman; C B Andersen; M Rasmussen; M Tvede
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-12       Impact factor: 3.267

6.  Late primary graft dysfunction after lung transplantation and bronchiolitis obliterans syndrome.

Authors:  H J Huang; R D Yusen; B F Meyers; M J Walter; T Mohanakumar; G A Patterson; E P Trulock; R R Hachem
Journal:  Am J Transplant       Date:  2008-09-10       Impact factor: 8.086

Review 7.  Primary graft dysfunction: lessons learned about the first 72 h after lung transplantation.

Authors:  Mary K Porteous; Joshua M Diamond; Jason D Christie
Journal:  Curr Opin Organ Transplant       Date:  2015-10       Impact factor: 2.640

8.  High-resolution human leukocyte antigen typing and early post-transplant outcomes: more than meets the eye.

Authors:  Annelore Sacreas; Stijn E Verleden
Journal:  Ann Transl Med       Date:  2020-02

Review 9.  Recipient-related clinical risk factors for primary graft dysfunction after lung transplantation: a systematic review and meta-analysis.

Authors:  Yao Liu; Yi Liu; Lili Su; Shu-juan Jiang
Journal:  PLoS One       Date:  2014-03-21       Impact factor: 3.240

10.  Lipoxin A4 attenuates the lung ischaemia reperfusion injury in rats after lung transplantation.

Authors:  Lijuan Zhang; Qihang Tai; Guangxiao Xu; Wei Gao
Journal:  Ann Med       Date:  2021-12       Impact factor: 4.709

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.